|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
10/28/2024 |
$51.95 |
$52.76 |
$51.81 |
$52.64 |
8.53M | 10/29/2024 |
$52.34 |
$52.74 |
$52.14 |
$52.50 |
8.37M | 10/30/2024 |
$52.50 |
$53.15 |
$52.29 |
$52.66 |
9.65M | 10/31/2024 |
$53.80 |
$56.20 |
$53.56 |
$55.77 |
18.74M | 11/01/2024 |
$55.88 |
$55.90 |
$54.20 |
$54.32 |
12.89M |
|
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy. | |
|
Bristol Myers Squibb (BMY) has the following price history information. Looking back at BMY historical stock prices for the last five trading days, on October 28, 2024, BMY opened at $51.95, traded as high as $52.76 and as low as $51.81, and closed at $52.64. Trading volume was a total of 8.53M shares. On October 29, 2024, BMY opened at $52.34, traded as high as $52.74 and as low as $52.14, and closed at $52.50. Trading volume was a total of 8.37M shares. On October 30, 2024, BMY opened at $52.50, traded as high as $53.15 and as low as $52.29, and closed at $52.66. Trading volume was a total of 9.65M shares. On October 31, 2024, BMY opened at $53.80, traded as high as $56.20 and as low as $53.56, and closed at $55.77. Trading volume was a total of 18.74M shares. On November 01, 2024, BMY opened at $55.88, traded as high as $55.90 and as low as $54.20, and closed at $54.32. Trading volume was a total of 12.89M shares.
BMY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bristol Myers Squibb shares, starting with a $10,000 purchase of BMY, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
11/04/2014 |
|
End date: |
11/01/2024 |
|
Start price/share: |
$57.84 |
|
End price/share: |
$54.32 |
|
Starting shares: |
172.89 |
|
Ending shares: |
236.09 |
|
Dividends reinvested/share: |
$18.40 |
|
Total return: |
28.24% |
|
Average Annual Total Return: |
2.52% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12,824.97 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/04/2014 |
|
End date: |
11/01/2024 |
|
Start price/share: |
$57.84 |
|
End price/share: |
$54.32 |
|
Dividends collected/share: |
$18.40 |
|
Total return: |
25.73% |
|
Average Annual Total Return: |
2.32% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12,577.03 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
10/28/2024 | $52.64 | 10/29/2024 | $52.50 | 10/30/2024 | $52.66 | 10/31/2024 | $55.77 | 11/01/2024 | $54.32 |
|
|